(16005870), G. N. S., (16005873), P. A. K., (16005876), K. V. G., (16005879), J. D. M., (15036341), M. D. C., (16005882), B. A. A., . . . (16005897), T. W. M. (2025). Supplementary Tables 1-8 from Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER<sup>+</sup> Breast Cancer.
Chicago Style (17th ed.) Citation(16005870), Gary N. Schwartz, et al. Supplementary Tables 1-8 from Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER<sup>+</sup> Breast Cancer. 2025.
MLA (9th ed.) Citation(16005870), Gary N. Schwartz, et al. Supplementary Tables 1-8 from Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER<sup>+</sup> Breast Cancer. 2025.